county St. Louis: Latest News

Bharat Biotech's intranasal Covid vaccine to be launched on 26 January; here's all you need to know

Here's all you need to know about India's first of its kind Covid vaccine: The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein. This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results. The vaccine was developed in partnership with Washington University, St.

Louis, which had designed and developed the recombinant adenoviral vectored construct and evaluated in preclinical studies for efficacy. The intranasal vaccine is stable at 2-8°C for easy storage and distribution and has been designed for efficient distribution and easy pain free administration. This vaccine has been specifically formulated to allow intranasal delivery through nasal drops.

The nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. As a needle-less vaccine, iNCOVACC will be India’s first such booster dose.

covid-19 vaccine Government platform reports Immunic Manufacturing

All news where county St. Louis is mentioned